Anti-EGF antibodies as surrogate biomarkers of clinical...

OncoImmunology 2020 / 01 Vol. 9; Iss. 1

Anti-EGF antibodies as surrogate biomarkers of clinical efficacy in stage IIIB/IV non-small-cell lung cancer patients treated with an optimized CIMAvax-EGF vaccination schedule

Popa, Xitlally, García, Beatriz, Fuentes, Karla P., Huerta, Vivian, Alvarez, Karen, Viada, Carmen E., Neninger, Elia, Rodríguez, Pedro C., González, Zuyen, González, Amnely, Crombet, Tania, Mazorr
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
9
Journal:
OncoImmunology
DOI:
10.1080/2162402X.2020.1762465
Date:
January, 2020
File:
PDF, 3.25 MB
2020
Conversion to is in progress
Conversion to is failed